Physician profile
Manjari Nathan
NPI 1033386503
$8,505.92
in general payments reported to CMS, 2019-2025
36 companies · $2,607 in 2025
The $2,607 reported for 2025 was more than what 80% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,176 · 2020: $236 · 2021: $572 · 2022: $1,163 · 2023: $816 · 2024: $937 · 2025: $2,607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,047 · Travel and Lodging: $929 · Education: $383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,046.74 |
| Travel and Lodging | $929.41 |
| Education | $383.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $2,262.40 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,287.29 | 2019-2025 | Ofev, Jascayd |
| Medical Device Business Services, INC. | $1,028.54 | 2025 | Monarch |
| Astrazeneca Pharmaceuticals LP | $782.53 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $469.79 | 2019-2025 | Trelegy Ellipta, Nucala |
| Actelion Pharmaceuticals US, INC. | $271.59 | 2019-2022 | |
| Inspire Medical Systems, INC. | $233.48 | 2024-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $229.21 | 2023-2024 | |
| Harmony Biosciences LLC | $177.22 | 2021-2024 | |
| Sanofi-Aventis U.S. LLC | $167.74 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $160.71 | 2020-2025 | Zerbaxa, Recarbrio |
| Janssen Pharmaceuticals, INC | $144.82 | 2019-2024 | Xarelto |
| Takeda Pharmaceuticals U.S.A., INC. | $128.88 | 2020-2023 | Glassia |
| Advanced Respiratory, INC | $104.03 | 2019-2021 | |
| Fisher & Paykel Healthcare INC | $94.20 | 2024-2025 | Fisher & Paykel Healthcare |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $87.56 | 2022-2025 | Tezspire |
| Vanda Pharmaceuticals INC. | $86.63 | 2022-2023 | Hetlioz |
| Ethicon INC. | $84.54 | 2021-2022 | |
| La Jolla Pharmaceutical Company | $76.60 | 2023-2024 | Giapreza |
| Baxter Healthcare | $74.83 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| United Therapeutics Corporation | $67.53 | 2025 | Tyvaso |
| Bayer Healthcare Pharmaceuticals INC. | $65.54 | 2020-2022 | |
| Abbvie INC. | $60.42 | 2022 | |
| Lilly USA, LLC | $58.91 | 2025 | Zepbound |
| Melinta Therapeutics, LLC | $43.04 | 2024 | Vabomere, Rezzayo, Kimyrsa |
| Resmed Corp | $42.39 | 2020-2024 | |
| Insmed, INC. | $39.29 | 2024 | Arikayce |
| Philips North America LLC | $32.90 | 2021 | |
| Genentech USA, INC. | $28.88 | 2019-2020 | |
| Avadel Cns Pharmaceuticals, LLC | $28.75 | 2024 | Lumryz |
| Verona Pharma, INC. | $18.00 | 2025 | Ohtuvayre |
| Apria Healthcare LLC | $17.80 | 2021 | |
| Pulmonx Corporation | $16.75 | 2021 | |
| Circassia INC. | $14.64 | 2019 | |
| Shire North American Group INC | $10.84 | 2019 | |
| Itamar Medical INC | $7.65 | 2023 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manjari Nathan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.